Coronavirus ACE Inhibitor Investigation

Details

Instance of

clinical trial

Start time

30 March 2020

End time

31 January 2021

Country

Ireland

Main subject

blood pressure, pandemic, antihypertensive drug, ACE inhibitor, angiotensin receptor antagonist, ATC code C03, arterial hypertension

clinical trial phase

phase IV clinical trial

minimum age

60

number of participants

2414

research intervention

hydrochlorothiazide, antihypertensive drug, angiotensin receptor antagonist, ATC code C03, ACE inhibitor

short name

CORONACION

sponsor

National University of Ireland

study type

interventional study

title

CORONAvirus ACE Inhibitor InvestigatiON: A Randomized Study